Skip to content

Clinical trials

Muscular Dystrophy, Duchenne trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Country / region: Poland Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20131
20142
20161
20171
20181
20202
20212
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Active, not recruiting3
Recruiting2
Unknown status2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PTC Therapeutics3
Sarepta Therapeutics, Inc.3
GlaxoSmithKline2
Medical University of Gdansk2
BioMarin Pharmaceutical1
Centre Hospitalier Universitaire de Liege1
Hoffmann-La Roche1
Italfarmaco1
Pfizer1
Satellos Bioscience, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne16
Muscular Dystrophies6
Neuromuscular Diseases4
Genetic Diseases, Inborn3
Genetic Diseases, X-Linked3
Muscular Diseases3
Muscular Disorders, Atrophic3
Musculoskeletal Diseases3
Nervous System Diseases3
Charcot-Marie-Tooth Disease1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.